Recent developments might have scared away some investors, but patience could pay off.Over the past five years, diabetes-focused medical device specialist DexCom (DXCM -0.50%) has made meaningful progress on several fronts. The company launched new products in the continuous glucose monitoring (CGM) niche and entered new geographies. Its revenue has generally increased at a good pace on a year-over-year basis.However, after a recent plunge, DexCom has underperformed the S&P 500 in the past half-decade. Can ...

SAN DIEGO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the DexCom class action lawsuit – captioned Alonzo v. DexCom, Inc., No. 24-cv-01485 (S.D. Cal.) – charges DexCom, Inc. (NASDAQ: DXCM) and certain of DexCom’s top executives with violations of the Securities Exchange Act of 1934. Subsequently filed complaints are captioned Oakland County Employees’ Retirement System v. DexCom, Inc., No. 24-cv-01804 (S.D. Cal.), and Carnes v. DexCom, Inc., No. 24-cv-01809 (S.D. Cal.). ...

Wall Street expects a year-over-year decline in earnings on higher revenues when DexCom (DXCM) reports results for the quarter ended September 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on October 24, 2024, might help the stock move higher if these key numbers are better than expec ...

RADNOR, Pa., Oct. 17, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against DexCom, Inc. ("DexCom") (NASDAQ: DXCM) on behalf of investors who purchased or otherwise acquired DexCom securities between April 28, 2023 and July 25, 2024, inclusive (the "Class Period") The lead plaintiff deadline is October 21, 2024.CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:If you suffered DexCom losses, you may CLIC ...

NEW YORK, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the Company’s senior executives. If you invested in DexCom, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/dexcom-inc. Investors have until October 21, 2024 to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and ...

NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM). Shareholders who purchased shares of DXCM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/dexcom-inc-loss-submission-form/?id=108483&from=3 CLASS PERIOD: This lawsuit is on be ...

DexCom (NASDAQ: DXCM ) has been unable to recover from its disastrous Q2 earnings it published a quarter ago, where it surprised everyone with its abysmal outlook for the rest of the year.Uttam is a growth-oriented investment analyst whose equity research primarily focuses on the technology sector. Semiconductors, Artificial Intelligence and Cloud software are some of the key sectors that are regularly researched and published by him. His research also focuses on other areas such as MedTech, Defense Tech, a ...

NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the Company’s senior executives. If you invested in DexCom, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/dexcom-inc. Investors have until October 21, 2024 to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and ...

SAN DIEGO, Oct. 15, 2024 (GLOBE NEWSWIRE) --  Robbins Geller Rudman & Dowd LLP announces that the DexCom class action lawsuit – captioned Alonzo v. DexCom, Inc., No. 24-cv-01485 (S.D. Cal.) – charges DexCom, Inc. (NASDAQ: DXCM) and certain of DexCom’s top executives with violations of the Securities Exchange Act of 1934. Subsequently filed complaints are captioned Oakland County Employees’ Retirement System v. DexCom, Inc., No. 24-cv-01804 (S.D. Cal.), and Carnes v. DexCom, Inc., No. 24-cv-01809 (S.D. Cal.) ...

NEW YORK, Oct. 14, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM).Shareholders who purchased shares of DXCM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/dexcom-inc-loss-submission-form/?id=107869&from=4CLASS PERIOD: This lawsuit is on behalf of ...